Buscar | Pikumil

Priyanka Bhingare agregó una foto Other
2025-12-23 06:33:57 -

Global Dasatinib Drugs Market Strategic Analysis
The Global Dasatinib Drugs Market Size Was Valued at USD 1.36 Billion in 2023 and is Projected to Reach USD 2.5 Billion by 2032, Growing at a CAGR of 6.98% From 2024-2032. Dasatinib is a potent, second-generation tyrosine kinase inhibitor (TKI) primarily utilized in the treatment of specific types of blood cancers, most notably Philadelphia chromosome-positive ($Ph+$) Chronic Myeloid Leukemia...

0 Commentarios 0 Acciones 380 Views 0 Vista previa

Please log in to like, share and comment!
Rutuja Deshmukh agregó una foto Other
2026-06-11 19:00:45 -

Dasatinib Market Growth in Emerging Healthcare Markets
The global Dasatinib Market was valued at USD 5.6 billion in 2025 and is projected to reach USD 7.6 billion by 2033, expanding at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady growth due to the increasing prevalence of hematologic cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)....

0 Commentarios 0 Acciones 44 Views 0 Vista previa

Please log in to like, share and comment!